ストックスクリーナーアプリを入手
6.72
6.67%
0.42
前日終値:
$6.30
開ける：
$6.22
24時間の取引高:
12,363
Relative Volume:
0.65
時価総額：
$92.66M
収益：
$49.98M
当期純損益:
$-9.64M
株価収益率:
-9.4648
EPS:
-0.71
ネットキャッシュフロー:
$-4.86M
1週間 パフォーマンス:
+11.26%
1か月 パフォーマンス:
-2.18%
6か月 パフォーマンス:
-9.13%
1年 パフォーマンス:
+30.23%
1日の値動き範囲:
$6.22
$6.9999
1週間の範囲:
$6.07
$6.9999
52週間の値動き範囲:
$4.9715
$11.99
Champions Oncology Inc Stock (CSBR) Company Profile
名前
Champions Oncology Inc
セクター
電話
410-369-0365
住所
855 N. WOLFE STREET, BALTIMORE, NJ
CSBR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
6.72 | 86.87M | 49.98M | -9.64M | -4.86M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-12 | アップグレード | Craig Hallum | Hold → Buy |
| 2019-11-18 | 開始されました | The Benchmark Company | Speculative Buy |
Champions Oncology Inc (CSBR) 最新ニュース
Investors in Champions Oncology (NASDAQ:CSBR) from five years ago are still down 41%, even after 11% gain this past week - simplywall.st
Ocean Power Tech, Champions Oncology set to report earnings Monday By Investing.com - Investing.com Canada
Ocean Power Tech, Champions Oncology set to report earnings Monday - Investing.com
Insights Ahead: Champions Oncology's Quarterly Earnings - Benzinga
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025 - ACCESS Newswire
Shareholders in Champions Oncology (NASDAQ:CSBR) are in the red if they invested five years ago - Yahoo Finance
Will Champions Oncology Inc. (2I3) stock beat value stocks2025 Stock Rankings & Expert Curated Trade Setups - Newser
Will Champions Oncology Inc. stock deliver consistent dividendsJuly 2025 Review & AI Enhanced Trade Execution Alerts - Newser
Will Champions Oncology Inc. (2I3) stock outperform benchmarksInflation Watch & Technical Pattern Based Buy Signals - Newser
Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH) and Champions Oncology (CSBR) - The Globe and Mail
Why (CSBR) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Why Champions Oncology Inc. (2I3) stock is a strong buy callWeekly Trade Recap & Breakout Confirmation Alerts - Newser
Will Champions Oncology Inc. stock benefit from infrastructure spending2025 Performance Recap & Step-by-Step Swing Trade Plans - Newser
Why pension funds invest in Champions Oncology Inc. (2I3) stock2025 Top Gainers & Verified Short-Term Trading Plans - Newser
Will Champions Oncology Inc. (2I3) stock deliver stable dividendsJuly 2025 Trends & Weekly Return Optimization Alerts - Newser
What drives Champions Oncology Inc 2I3 stock priceMonthly Performance Summary & Achieve Triple Digit Returns - earlytimes.in
Patient-Derived Xenograft Model Market Size at USD 1.12 Billion in 2031, Forecasted to Grow at 13.4% CAGR Through 2031 | The Insight Partners (PR Newswire) - Aktiellt
Understanding Momentum Shifts in (CSBR) - news.stocktradersdaily.com
Will Champions Oncology Inc. stock outperform Nasdaq indexWeekly Stock Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Quantitative breakdown of Champions Oncology Inc. recent move2025 Big Picture & Verified Entry Point Signals - newser.com
What dividend safety rating applies to Champions Oncology Inc. (2I3) stockDip Buying & Free Fast Entry Momentum Trade Alerts - newser.com
How Champions Oncology Inc. (2I3) stock behaves in tightening cycles2025 Pullback Review & Free Weekly Chart Analysis and Trade Guides - newser.com
Candlestick signals on Champions Oncology Inc. stock todayJuly 2025 Levels & Risk Adjusted Swing Trade Ideas - newser.com
Published on: 2025-11-19 21:53:34 - newser.com
How Champions Oncology Inc. (2I3) stock reacts to weak economy - newser.com
Why Champions Oncology Inc. is moving todayPortfolio Growth Summary & Real-Time Buy Signal Alerts - newser.com
Is Champions Oncology Inc. stock a buy in volatile marketsEarnings Recap Summary & Short-Term High Return Strategies - newser.com
Champions Oncology, Inc.Common Stock (NQ: CSBR - FinancialContent
Craig-Hallum Maintains Champions Oncology(CSBR.US) With Buy Rating, Announces Target Price $12 - 富途牛牛
Champions Oncology Inc (CSBR) 財務データ
収益
当期純利益
現金流量
EPS
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):